INAB Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Advances Pipeline CDIO Q1 2025 Earnings Loss Narrows Beats Estimates Amid PreRevenue Stage CAC Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations ETR Q1 2026 Earnings EPS Slightly Misses Estimates Amid Operational Challenges JRVR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum